Bölüm notları
Dr.
Alo and Hannah unpack FLOWPROMOTE, a new JAMA Cardiology trial that used full coronary CT scans to track plaque changes in statin naive patients over eighteen months. They explain why soft plaque shrank in 98 percent of patients on rosuvastatin plus ezetimibe, and why a rising calcium score during treatment is actually a good sign, not a warning. Listeners walk away with a clear picture of what the LDL and plaque numbers really mean for their own heart health.
https://dralo.net/links
Read the full post: https://www.dralo.net/blog/reverse-soft-plaque
Questions this episode…
Web sitesi: dralo.net

